YOLFTbeta
Imugene Ltd

Imugene Ltd

IMU · AU · Healthcare / Biotechnology

0.036AUD+0.00 (+2.86%)

Price History

Full chart

Market Stats

Previous Close0.035
Open0.035
Day Range0.034 – 0.036
52-Week Range0.037 – 0.46
Volume528.88K
Market Cap20.62M
P/E (TTM)0.00
Forward P/E13.30
EPS-0.32
Dividend Yield0.00%
Beta2.07
50-Day Avg0.0671
200-Day Avg0.1535

About

Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA, a combination of genomic sequences from various vaccinia virus strains to generate potent virus in phase 1 clinical trial for mixed advanced solid tumours; and CF33 CD19 chimeric antigen receptor T cells therapies to target solid tumours in phase 1 study. The company also develops CF33 oncolytic virotherapy; HER-VAXX, a B-cell immunotherapy cancer vaccine completed phase 2 clinical trial to target metastatic gastric cancer; PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling in phase 2 clinical trial to target non-small cell lung cancer; and Neo-POLEM in phase 2 study for MSI-high colorectal cancer. Imugene Limited is headquartered in Sydney, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD
  • Employees14
  • Headquarters4-6 Bligh Street, Sydney, NSW, Australia, 2000, Australia
  • Websitehttps://imugene.com

Leadership

  • Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICDExecutive Chairman · b. 1956
  • Mr. Darren Michael Keamy B.Com., CPACFO & Company Secretary · b. 1973
  • Dr. John Byon M.D., Ph.D.Chief Medical Officer
  • Ms. Ursula McCurryChief Clinical Operations Officer

Financials

Income Statement

Currency: AUD1993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue--188.00K278.00K3.86M-964.27K339.00K114.24K1.29M19124.00K390.00K263.00K1.57K92.00K3.02M44.00K2.23M235.91K207.22K538.31K638.68K1.56M1.16M1.84M4.13M4.13M7.23M12.97M11.78M4.97M4.40M-
Growth (%)---+47.87%+1288.13%---64.84%-66.30%+1030.96%-100.00%+652531.58%+214.52%-32.56%-99.40%+5752.42%+3186.96%-98.54%+4961.36%-89.41%-12.16%+159.78%+18.64%+144.88%-25.58%+58.16%+124.17%+0.17%+74.94%+79.34%-9.19%-57.80%-11.53%-
Cost of Revenue------07.67M107.19K175.00K324.00K537.00K463.00K498.00K731.00K789.00K704.00K179.00K1.32M-676001.16K1.74K2.68K63.26K82.50K1.96M2.41M2.20M5.84M3.38M6.84M
Gross Profit--188.00K278.00K3.86M-964.27K612.44K7.04K1.12M19---1.57K---2.23M235.91K207.22K538.31K638.68K1.56M1.16M1.84M4.06M4.05M5.27M10.56M9.57M4.97M4.40M-6.84M
Gross Margin--100.00%100.00%100.00%-100.00%180.66%6.17%86.46%100.00%---100.00%---100.00%100.00%100.00%100.00%100.00%99.94%99.83%99.84%98.47%97.99%72.86%81.44%81.29%100.00%100.00%-
Operating Expense--935.00K871.00K0-5.87M5.01M2.58M329.28K2.43M---3.04M---1.89M1.40M1.95M1.34M2.88M5.83M4.85M7.62M16.45M14.86M30.93M61.24M60.87M145.90M75.34M68.11M
Operating Income-262.00K-766.00K-747.00K-593.00K3.86M-4.52M-4.90M-4.40M-2.57M787.72K-2.43M-2.43M-2.51M-2.81M-3.04M-2.56M-2.76M-2.12M338.94K-1.17M-1.74M-797.00K-2.25M-4.27M-3.69M-5.78M-12.39M-10.80M-25.67M-50.67M-51.29M-140.93M-70.94M-74.95M
Operating Margin---397.34%-213.31%100.00%--508.47%-1298.23%-2250.54%60.97%-12784210.53%-1962.90%-644.36%-1066.92%-193447.84%-2780.43%-91.17%-4820.45%15.22%-494.68%-839.20%-148.06%-351.67%-272.95%-316.58%-313.85%-300.19%-261.37%-354.89%-390.70%-435.50%-2835.62%-1613.45%-
EBITDA-305.00K-871.00K-1.51M-4.15M-2.11M-4.52M-4.90M-4.40M-3.42M1.12M-2.30M-1.62M-1.96M-2.09M-2.69M-2.22M-2.41M-1.42M682.09K-995.00K-1.74M-2.62M-195.00K-4.25M-3.67M-5.77M-7.71M-14.55M-23.72M-48.06M-47.42M-147.98M-67.42M-68.11M
EBITDA Margin---804.79%-1491.73%-54.78%--508.47%-1298.23%-2994.60%86.46%-12084210.53%-1304.03%-503.59%-795.82%-171437.66%-2408.70%-79.83%-3231.82%30.63%-421.77%-841.14%-487.45%-30.53%-271.55%-315.21%-313.53%-186.72%-352.06%-327.97%-370.56%-402.66%-2977.41%-1533.46%-
Net Income243.00K-875.00K-2.13M-4.24M-2.18M-4.55M-4.93M-4.42M-4.04M-782.00K699.06K-2.12M-1.79M-2.19M-2.30M-1.91M650.29K-1.53M415.54K-3.13M-1.56M-2.12M-2.44M-2.73M-2.51M-3.93M-7.78M-10.51M-18.45M-37.87M-37.91M-149.68M-69.02M-105.34M
Net Income Margin---1135.64%-1526.62%-56.54%--511.27%-1303.54%-3537.32%-60.53%3679263.16%-1706.45%-460.00%-831.56%-146564.89%-2077.17%21.50%-3488.64%18.66%-1328.04%-752.82%-393.08%-382.20%-174.62%-215.38%-213.69%-188.39%-254.18%-255.19%-291.97%-321.91%-3011.67%-1569.81%-
R&D------1.33M1.72M--943.96K1.36M810.38K1.09M1.08M1.13M466.48K522.34K491.69K285.44K603.32K469.46K1.91M2.70M2.47M4.15M7.61M9.36M15.36M36.61M30.86M86.89M46.69M50.89M
R&D as % of Total Revenue------137.51%508.50%--4968205.26%1097.58%207.79%415.21%68511.45%1231.52%15.43%1187.13%22.08%120.99%291.15%87.21%299.06%172.51%212.37%225.31%184.44%226.51%212.32%282.28%262.06%1748.18%1061.94%-
Interest Expense23.00K33.00K097.00K68.00K28.00K27.00K18.00K180.95K000000000000000006.11K5.03K5.02K13.58K27.45K478.36K162.49K125.48K
Interest Expense % of Total Revenue--0.00%34.89%1.76%-2.80%5.31%158.40%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.15%0.12%0.07%0.10%0.23%9.62%3.70%-

Balance Sheet

Currency: AUD1993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets5.70M11.31M11.93M9.25M8.69M7.89M6.89M3.68M2.44M844.39K8.14M6.02M9.06M7.27M5.26M5.16M5.76M4.10M4.69M1.32M2.58M8.63M9.11M9.54M12.68M16.91M30.78M65.20M71.81M147.61M197.06M151.40M83.59M23.03M
Total Liabilities587.00K127.00K1.30M1.13M1.24M1.14M898.00K903.09K2.67M51.56K700.77K584.29K411.52K806.04K560.55K493.37K436.72K307.37K480.28K244.97K698.03K1.90M1.38M1.68M1.28M1.44M3.48M5.40M6.79M8.90M7.44M33.14M38.56M14.02M
Total Equity5.11M11.19M10.62M8.12M7.45M6.75M6.00M2.78M-226.54K792.83K7.44M5.43M8.65M6.46M4.70M4.67M5.33M3.79M4.21M1.07M1.89M6.73M7.73M7.86M11.39M15.48M27.29M59.81M65.02M138.70M189.63M118.25M45.03M9.01M
Cash18.00K5.56M251.00K-689.00K2.04M1.81M2.11M402.00K28.56K783.00K2.62M962.74K4.35M2.70M1.10M1.62M2.49M793.06K1.91M1.02M565.63K1.22M1.96M1.58M4.81M7.82M19.05M30.11M29.49M99.89M153.15M93.11M21.94M2.63M
Total Debt61.00K34.00K625.00K693.00K564.00K604.00K241.00K285.00K1.22M-----------------1.11M69.34K271.03K673.43K553.48K2.19M10.65M6.30M
Net Debt43.00K-5.52M374.00K1.38M-1.47M-1.21M-1.87M-117.00K1.19M-783.00K-2.62M-962.74K-4.35M-2.70M-1.10M-1.62M-2.49M-793.06K-1.91M-1.02M-565.63K-1.22M-1.96M-1.58M-4.81M-7.82M-18.93M-30.04M-29.22M-99.21M-152.60M-90.91M-11.28M3.67M

Cash Flow

Currency: AUD1993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-198.00K-1.46M-1.67M-2.02M-2.15M--3.45M-3.95M-2.55M-787.36K--1.52M-1.63M-1.83M-1.70M-1.27M881.77K-1.74M1.09M-965.92K-1.37M-1.14M-2.04M-3.05M-2.67M-4.51M-7.91M-10.13M-13.13M-30.67M-29.78M-101.73M-75.57M-44.85M
Investing Cash Flow-7.00K562.00K-5.80M179.00K2.81M-241.00K-228.00K985.00K-31.47K--362.66K-241.47K-2.49K183.93K104.83K65.94K76.61K40.78K11.17K8.68K17.49K-594.39K-463.62K-90.76K-2.34K-412.90K247.39K-1.52M-5.48M-414.16K9.63K-7.25M-12.70M-4.35M
Financing Cash Flow209.00K6.46M2.18M1.60M1.38M3.69M3.97M1.27M2.21M1.54M3.59M105.39K5.02M--1.73M----927.62K2.40M3.24M2.74M5.93M7.93M18.77M22.71M17.99M101.35M82.98M49.43M17.37M29.99M
Capital Expenditure7.00K469.00K2.27M79.00K167.00K241.00K228.00K183.00K31.47K023.83K7.17K2.49K12.63K02.50K03.24K000600.19K463.62K4.11K2.03K3.33K128.39K1.49M5.45M257.69K07.07M14.46M5
Free Cash Flow-205.00K-1.92M-3.94M-2.10M-2.32M-241.00K-228.00K-4.13M-2.58M-787.36K-23.83K-1.53M-1.63M-1.85M-1.70M-1.28M881.77K-1.75M1.09M-965.92K-1.37M-1.74M-2.51M-3.05M-2.68M-4.51M-8.04M-11.62M-18.58M-30.93M-29.78M-108.80M-90.03M-44.85M
Dividends Paid-----------------------00--20.91M17.94M6.01M77.94M---
FCF to OCF103.54%132.23%236.19%103.91%107.76%-6.61%104.63%101.23%100.00%-100.47%100.15%100.69%100.00%100.20%100.00%100.19%100.00%100.00%100.00%152.46%122.69%100.13%100.08%100.07%101.62%114.67%141.49%100.84%100.00%106.95%119.13%100.00%
Dividend Paid to FCF-----------------------0.00%0.00%---179.93%-96.55%-19.42%-261.73%---

Earnings

Report DateFeb 29, 2016Sep 28, 2016Feb 28, 2017Aug 31, 2017Feb 27, 2018Aug 31, 2018Feb 27, 2019Aug 30, 2019Feb 26, 2020Aug 31, 2020Feb 26, 2021Aug 30, 2021Feb 27, 2022Jun 1, 2022Aug 31, 2022Nov 30, 2022Feb 28, 2023Apr 28, 2023Aug 25, 2023Oct 31, 2023Feb 28, 2024May 29, 2024Aug 30, 2024Nov 27, 2024Feb 27, 2025May 28, 2025Aug 25, 2025Dec 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00-0.00-0.000.000.000.000.000.000.000.000.000.00-0.010.000.000.00-0.010.00
EPS Actual0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.010.00-0.090.00
Surprise-----------100.00%100.00%---------100.00%----800.00%-
Timing--------------Pre-market-After-hoursAfter-hoursPre-marketPre-market--------

Key Statistics & Ratios

Market Cap20.62M
Enterprise Value28.19M
Trailing P/E0.00
Forward P/E13.30
PEG Ratio4.07
Price / Sales9.88
Price / Book2.72
EPS-0.32
Book Value0.022
Revenue (TTM)2.09M
Gross Profit (TTM)2.09M
EBITDA-99.92M
Profit Margin0.00%
Operating Margin-5246.19%
Return on Equity-313.99%
Return on Assets-123.50%
Shares Outstanding557.27M
Shares Float438.21M
Beta2.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
9.52%
Insiders
9.31%
Retail / Other
81.17%

Top Fund Holders

  • DFA International Sustainability Core 1 Portfolio
    1.29M0.03%

Stock Splits

  • Jul 2, 20251:34
  • Nov 11, 20021:7.5
  • Jan 29, 20021:5
  • Jan 8, 19961.0027:1